ATE169228T1 - Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen - Google Patents

Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen

Info

Publication number: ATE169228T1
Authority: AT; Austria
Prior art keywords: penetractability; improving; topically applicable; vitamin; penetration
Prior art date: 1991-10-23

Application number

AT92309727T

Other languages

English (en)

Inventor

Joseph Synodis

Stuart Wilensky

Original Assignee

Stafford Miller Continental Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-23

Filing date

1992-10-23

Publication date

1998-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25135484&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE169228(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-10-23 Application filed by Stafford Miller Continental Nv filed Critical Stafford Miller Continental Nv

1998-08-15 Application granted granted Critical

1998-08-15 Publication of ATE169228T1 publication Critical patent/ATE169228T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 abstract 4
229930003427 Vitamin E Natural products 0.000 abstract 2
WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract 2
229940046009 vitamin E Drugs 0.000 abstract 2
235000019165 vitamin E Nutrition 0.000 abstract 2
239000011709 vitamin E Substances 0.000 abstract 2
239000008406 cosmetic ingredient Substances 0.000 abstract 1
239000006071 cream Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000002708 enhancing effect Effects 0.000 abstract 1
-1 etc. ) Substances 0.000 abstract 1
239000010408 film Substances 0.000 abstract 1
239000000499 gel Substances 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
239000006210 lotion Substances 0.000 abstract 1
239000002674 ointment Substances 0.000 abstract 1
239000006072 paste Substances 0.000 abstract 1
230000035515 penetration Effects 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
239000000725 suspension Substances 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dermatology (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Oil, Petroleum & Natural Gas (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT92309727T 1991-10-23 1992-10-23 Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen ATE169228T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US78542691A	1991-10-23	1991-10-23

Publications (1)

Publication Number	Publication Date
ATE169228T1 true ATE169228T1 (de)	1998-08-15

Family

ID=25135484

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92309727T ATE169228T1 (de)	1991-10-23	1992-10-23	Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen

Country Status (11)

Country	Link
US (1)	US6017520A (de)
EP (1)	EP0539215B1 (de)
JP (1)	JP2671248B2 (de)
KR (1)	KR930007445A (de)
AT (1)	ATE169228T1 (de)
AU (1)	AU658681B2 (de)
CA (1)	CA2081269C (de)
DE (1)	DE69226491T2 (de)
DK (1)	DK0539215T3 (de)
ES (1)	ES2119800T3 (de)
NZ (1)	NZ244862A (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU223042B1 (hu) *	1993-04-20	2004-03-01	Hexal Ag.	Parkinson-kór kezelésére alkalmas hatóanyagot tartalmazó tapasz
CN1129400A (zh) *	1994-05-06	1996-08-21	阿尔康实验室公司	维生素e生育酚衍生物在眼科组合物中的应用
GB9409778D0 (en)	1994-05-16	1994-07-06	Dumex Ltd As	Compositions
WO1996020712A1 (en) *	1994-12-30	1996-07-11	American Home Products Corporation	Clear non-alcoholic hydrocortisone solutions
AU711716B2 (en)	1995-04-21	1999-10-21	Sekisui Kagaku Kogyo Kabushiki Kaisha	External preparations for treating dermatoses
CN1087931C (zh)	1996-03-14	2002-07-24	庄臣消费者有限公司	洗净与润湿表面活性剂组合物
US6730679B1 (en)	1996-03-22	2004-05-04	Smithkline Beecham Corporation	Pharmaceutical formulations
IT1282778B1 (it) *	1996-05-31	1998-03-31	Giorgio Panin	Vitamina "e" acetato quale prodotto per applicazione topica
DE19646392A1 (de) *	1996-11-11	1998-05-14	Lohmann Therapie Syst Lts	Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
AUPO379596A0 (en) *	1996-11-22	1996-12-19	Soltec Research Pty Ltd	Percutaneous delivery system
US20040067212A1 (en) *	1998-03-11	2004-04-08	Kabushiki Kaisha Soken	Skin conditioner
KR20000000840A (ko) *	1998-06-03	2000-01-15	김영대	신규한 폴리옥시프로필렌폴리옥시에틸렌 비타민 e 및 그의제조방법
FR2761600B1 (fr)	1998-06-19	2000-03-31	Oreal	Composition moussante pour le lavage et le traitement des cheveux et/ou du cuir chevelu a base d'un principe actif, d'un tensioactif anionique, d'un tensioactif amphotere et d'un agent propenetrant
US20070191320A1 (en) *	1998-12-10	2007-08-16	Nexmed Holdings, Inc.	Methods of treatment for female sexual arousal disorder
US6486207B2 (en)	1998-12-10	2002-11-26	Nexmed (Holdings), Inc.	Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en)	1998-12-10	2004-11-30	Nexmed (Holdings) , Inc.	Compositions and methods for amelioration of human female sexual dysfunction
WO2000047182A1 (en) *	1999-02-12	2000-08-17	The Procter & Gamble Company	Cosmetic compositions containing vitamin b3 compounds
US6787342B2 (en) *	2000-02-16	2004-09-07	Merial Limited	Paste formulations
US6383505B1 (en)	2000-11-09	2002-05-07	Steris Inc	Fast-acting antimicrobial lotion with enhanced efficacy
US6429231B1 (en) *	2001-09-24	2002-08-06	Bradley Pharmaceuticals, Inc.	Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
ATE419835T1 (de) *	2002-05-06	2009-01-15	Elan Pharma Int Ltd	Nystatin-nanopartikelzusammensetzungen
MXPA04011808A (es) *	2002-05-31	2005-09-12	Univ Mississippi	Liberacion transmucosica de canabinoides.
DE10224612A1 (de) *	2002-06-04	2003-12-24	Lohmann Therapie Syst Lts	Wirkstoffhaltige filmförmige Zubereitungen mit verbesserter chemischer Stabilität, und Verfahren zu deren Herstellung
JP2004123633A (ja) *	2002-10-03	2004-04-22	Medorekkusu:Kk	外用製剤
US7374772B2 (en) *	2002-11-07	2008-05-20	Bommarito Alexander A	Topical antifungal treatment
US20040191279A1 (en) *	2003-03-28	2004-09-30	Klofta Thomas James	Tacky skin care compositions and articles having tacky skin care compositions disposed thereon
EP1725209A2 (de) *	2003-10-03	2006-11-29	The Procter & Gamble Company	Topische zusammensetzung
US20090304820A1 (en) *	2008-06-05	2009-12-10	Pankaj Modi	Solubilized benzoyl peroxide topical drug formulation for the treatment of acne
US9308268B2 (en) *	2005-02-14	2016-04-12	Transdermal Corp	Solubilized benzoyl peroxyde acne
US9314431B2 (en) *	2005-02-14	2016-04-19	Transdermal Corp	Solubilized benzoyl small molecule
US7563464B1 (en) *	2005-04-22	2009-07-21	Bruce Eric Hudkins	Treatment of mucosal membranes utilizing phytoestrogen
WO2008037809A1 (en) *	2006-09-29	2008-04-03	Abbott Gmbh & Co. Kg	Transmucosal administration of fibrate compounds and delivery system therefor
US8481591B2 (en)	2010-11-01	2013-07-09	Stiefel Research Australia Pty. Ltd.	Polymeric topical compositions
EP3562470A1 (de)	2016-12-29	2019-11-06	Nestlé Skin Health SA	Zusammensetzung mit einer vernetzten hyaluronsäure in kombination mit einer niedermolekularen hyaluronsäure und/oder einem mittel zur stimulierung der endogenen hyaluronsäuresynthese

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4177267A (en) *	1963-12-09	1979-12-04	Crown Zellerbach	Enhancing tissue penetration of physiologically active steroidal agents with DMSC
IN142640B (de) *	1975-01-17	1977-08-06	Johnson & Johnson
JPS5579318A (en) *	1978-12-07	1980-06-14	Taisho Pharmaceut Co Ltd	Poultice
JPS5610887A (en) *	1979-07-09	1981-02-03	Babcock Hitachi Kk	Handrall structure of joint portion of duct
JPS5855417A (ja) *	1981-09-27	1983-04-01	Nitto Electric Ind Co Ltd	医薬組成物
EP0343694B1 (de) *	1984-03-07	1992-11-25	Roshdy Dr. Ismail	Mittel zur Behandlung und zum Schutz der Haut
JPS60224638A (ja) *	1984-04-23	1985-11-09	Kao Corp	経皮吸収促進剤およびこれを含有する外用剤
US4824676A (en) *	1984-10-11	1989-04-25	Schering Corporation	Physiological means of enhancing transdermal delivery of drugs
US4886783A (en) *	1986-01-31	1989-12-12	Nelson Research & Development Co.	Penetration enhancers for transdermal delivery of systemic agents
US4917896A (en) *	1986-08-15	1990-04-17	Nelson Research & Development Co.	Penetration enhancers for transdermal delivery of systemic agents
US4808414A (en) *	1986-09-29	1989-02-28	Nelson Research & Development Co.	Amide penetration enhancers for transdermal delivery of systemic agents
GB8630721D0 (en) *	1986-12-23	1987-02-04	Unilever Plc	Cosmetic compositions
US4869897A (en) *	1987-10-22	1989-09-26	The Procter & Gamble Company	Photoprotection compositions comprising sorbohydroxamic acid
US4847069A (en) *	1987-10-22	1989-07-11	The Procter & Gamble Company	Photoprotection compositions comprising sorbohydroxamic acid and an anti-inflammatory agent
JP2663136B2 (ja) *	1988-05-02	1997-10-15	有限会社野々川商事	美白化粧料
DE58906975D1 (de) *	1988-08-02	1994-03-24	Ciba Geigy	Mehrschichtiges Pflaster.
EP0576605A4 (en) *	1991-03-19	1994-06-08	Vithal J Rajadhyaksha	Compositions and method comprising aminoalcohol derivatives as membrane penetration enhancers
US5215759A (en) *	1991-10-01	1993-06-01	Chanel, Inc.	Cosmetic composition

1992
- 1992-10-22 NZ NZ244862A patent/NZ244862A/en not_active IP Right Cessation
- 1992-10-22 AU AU27266/92A patent/AU658681B2/en not_active Expired
- 1992-10-22 JP JP4307998A patent/JP2671248B2/ja not_active Expired - Lifetime
- 1992-10-22 KR KR1019920019450A patent/KR930007445A/ko not_active Abandoned
- 1992-10-23 DE DE69226491T patent/DE69226491T2/de not_active Revoked
- 1992-10-23 EP EP92309727A patent/EP0539215B1/de not_active Revoked
- 1992-10-23 AT AT92309727T patent/ATE169228T1/de not_active IP Right Cessation
- 1992-10-23 DK DK92309727T patent/DK0539215T3/da active
- 1992-10-23 CA CA002081269A patent/CA2081269C/en not_active Expired - Lifetime
- 1992-10-23 ES ES92309727T patent/ES2119800T3/es not_active Expired - Lifetime
1997
- 1997-05-02 US US08/850,377 patent/US6017520A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2671248B2 (ja)	1997-10-29
CA2081269A1 (en)	1993-04-24
DE69226491T2 (de)	1999-01-14
US6017520A (en)	2000-01-25
CA2081269C (en)	2002-03-05
DE69226491D1 (de)	1998-09-10
JPH06128176A (ja)	1994-05-10
DK0539215T3 (da)	1999-05-03
EP0539215B1 (de)	1998-08-05
NZ244862A (en)	1995-07-26
EP0539215A1 (de)	1993-04-28
ES2119800T3 (es)	1998-10-16
AU2726692A (en)	1993-04-29
AU658681B2 (en)	1995-04-27
KR930007445A (ko)	1993-05-20

Legal Events

Date	Code	Title	Description
1999-01-15	UEP	Publication of translation of european patent specification
2005-09-15	RZN	Patent revoked

Publication	Publication Date	Title
ATE169228T1 (de)	1998-08-15	Verbesserung der durchdringungfähigkeit von topischen anwendbaren formulierungen
RU93047799A (ru)	1996-03-20	Композиции, содержащие ретиноевые кислоты и токоферол
ATE55247T1 (de)	1990-08-15	13-cis-vitamin-a-saeure als wirksubstanz enthaltende arzneimittel.
DK0582239T3 (da)	1999-12-06	Farmaceutisk og/eller kosmetisk formulering
ATE137665T1 (de)	1996-05-15	Kosmetisches mittel
FI88459B (fi)	1993-02-15	Foerfarande foer framstaellning av en foer intranasal applikation laemplig steroidkomposition
ATE161419T1 (de)	1998-01-15	Kosmetische zusammensetzung, die einen lipidstoff und eine hydroxy - oder ketofettsäure enthält
ATE98868T1 (de)	1994-01-15	Topisch kosmetisch anzuwendende depolymerisierte nukleinsaeuren enthaltende arzneizubereitungen.
DE69222318D1 (de)	1997-10-23	Hautpflegemittel
ATE29382T1 (de)	1987-09-15	Arzneimittel zur behandlung von haarausfall.
CA2210674A1 (fr)	1998-01-25	Nouvelles compositions topiques comprenant de tres faibles doses de melatonine ou ses derives et leur utilisation en cosmetique
IT7949034A0 (it)	1979-05-14	Perfezionamento nelle composizioni emollienti per emulsioni creme paste cosmetiche e simili
AU629445B2 (en)	1992-10-01	Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol
EP0274104A3 (de)	1988-09-21	13-cis-Retinsäure zur Verwendung in Präparaten gegen alternde Haut
DE69018570D1 (de)	1995-05-18	Wasserlösliche Vitamin A-Zubereitungen und deren Verwendung bei der Hautbehandlung.
ES545063A0 (es)	1986-09-01	Producto antiseptico
DE50010067D1 (de)	2005-05-25	Kosmetische oder pharmazeutische Zubereitungen für die topische Verabreichung mit verbesserter Stabilität
GB2184652B (en)	1989-08-23	Topical compositions containing hexyl nicotinate
ATE99929T1 (de)	1994-01-15	Behandlung von periodontoklasie mit retinsaeure.
FI88359C (fi)	1993-05-10	Foerfarande foer framstaellning av en kardiovaskulaer komposition att anvaendas lokalt
ATE271872T1 (de)	2004-08-15	Topische carbamazepin-formulierungen und deren verwendung
ATE88897T1 (de)	1993-05-15	Therapeutisches mittel, das einen extrakt von impatiens capensis enthaelt.